Ivp with ***NON IONIC*** contrast (DC) at Dr. Essa Lab

Ivp with ***NON IONIC*** contrast (DC) at Dr. Essa Lab

An Ivp with ***NON IONIC*** contrast (DC) is a specialized diagnostic imaging procedure utilized to evaluate the structure, function, and patency of the human urinary system. Also known as an Intravenous Pyelogram or excretory urography, this examination plays a pivotal role in modern uroradiology. By utilizing advanced digital radiography and fluoroscopy, the procedure provides a detailed, real-time anatomical and functional map of the kidneys, ureters, and urinary bladder. At Dr. Essa Lab in Karachi, Pakistan, this diagnostic test is performed under strict clinical protocols, ensuring high-resolution imaging and maximum patient safety through the exclusive use of premium non-ionic contrast media.

The urinary tract is responsible for filtering waste products from the blood, maintaining electrolyte balance, and regulating fluid volume. When structural abnormalities, obstructions, or functional deficits occur within this system, patients can experience severe symptoms such as hematuria (blood in the urine), debilitating flank pain, or recurrent infections. The Ivp with ***NON IONIC*** contrast (DC) works by injecting a radiopaque contrast agent into the patient’s venous system. This contrast is rapidly cleared from the bloodstream by the kidneys through glomerular filtration. As the contrast medium is concentrated in the renal tubules and excreted into the renal pelvis, ureters, and bladder, it attenuates X-ray beams, appearing bright white on the radiographic films. This allows the consultant radiologist to trace the entire path of urine flow and identify any anatomical deviations, filling defects, or functional delays.

The clinical importance of using non-ionic contrast media cannot be overstated. Historically, older ionic contrast agents were associated with a higher incidence of adverse hypersensitivity reactions, contrast-induced nephropathy (CIN), and physical discomfort such as severe heat sensations or nausea. Non-ionic contrast media (NICM), such as Iohexol or Iopamidol, possess a lower osmolality that closely matches human blood plasma. This significantly reduces chemical toxicity, minimizes endothelial irritation, and drastically lowers the risk of allergic or anaphylactoid reactions. Dr. Essa Lab, a pioneer in diagnostic excellence in Karachi, utilizes these advanced non-ionic agents to guarantee a safe, comfortable, and highly accurate diagnostic experience for all patients.

Clinical Procedure: What to Expect

Undergoing an Ivp with ***NON IONIC*** contrast (DC) requires careful coordination between the patient, the referring physician, and the radiology team at Dr. Essa Lab. To ensure the highest diagnostic quality and patient safety, specific preparation and procedural steps must be meticulously followed.

Patient Preparation

• Renal Function Screening: Because the contrast medium is excreted entirely by the kidneys, patients must provide a recent Serum Creatinine and estimated Glomerular Filtration Rate (eGFR) report (usually within 30 days of the test) to confirm adequate renal function.
• Fasting Requirements: Patients are instructed to remain Nil Per Os (NPO) or fast for 4 to 6 hours prior to the procedure. This minimizes bowel gas and prevents potential aspiration in the rare event of contrast-induced nausea.
• Bowel Preparation: To ensure clear visualization of the kidneys and ureters without interference from fecal matter or intestinal gas, a mild laxative or a low-residue diet may be recommended on the day before the examination.
• Allergy History and Pre-medication: Patients must inform the clinical staff of any history of asthma, severe allergies, or previous adverse reactions to iodinated contrast. If a high-risk profile is identified, a pre-medication regimen consisting of corticosteroids and antihistamines may be prescribed.
• Metformin Management: Diabetic patients taking Metformin-containing medications must consult their physician regarding temporary discontinuation of the drug on the day of the procedure and for 48 hours post-contrast to mitigate the risk of lactic acidosis.
• Comfortable Attire: Patients should wear loose, comfortable clothing. All metallic objects, including jewelry, belts, and zippers, must be removed before entering the X-ray suite to prevent imaging artifacts.

During the Procedure

• Baseline Scout Film: The procedure begins with the patient lying supine on the digital X-ray table. A preliminary plain abdominal radiograph (KUB) is taken to evaluate bowel preparation and identify any pre-existing radiopaque calculi (kidney stones) that might later be obscured by the contrast.
• Intravenous Access: A skilled nurse or technologist secures a peripheral intravenous (IV) cannula, typically in the antecubital fossa of the arm.
• Contrast Injection: The non-ionic contrast medium is carefully injected through the IV line. During the injection, patients may experience a transient warm flush, a metallic taste in the mouth, or a mild sensation of needing to urinate. These are normal physiological responses and resolve rapidly.
• Serial Radiographic Imaging: A series of timed radiographs are captured at precise intervals:
  • 1-Minute (Nephrogram Phase): Visualizes the renal parenchyma as the contrast fills the functional tissue of the kidneys.
  • 5-Minute (Pyelogram Phase): Captures the contrast filling the minor and major calyces and the renal pelvis.
  • 10-to-15-Minute (Ureteric Phase): Tracks the contrast as it transits down both ureters toward the bladder.
• Abdominal Compression: In some cases, a soft compression band is applied across the lower abdomen to temporarily retain contrast in the upper urinary tract, allowing for a more detailed evaluation of the renal calyces.
• Post-Void Radiograph: After the bladder is fully visualized, the patient is asked to empty their bladder. A final post-void radiograph is immediately taken to assess the bladder’s emptying capacity and measure any residual urine volume.
• Duration: The entire procedure typically takes between 45 to 60 minutes, depending on the transit time of the contrast through the patient’s urinary system.

When is a Ivp with ***NON IONIC*** contrast (DC) Performed?

Physicians request this specialized imaging study to investigate a variety of clinical signs, symptoms, and suspected urological conditions. Below are the primary clinical indications for this procedure.

Evaluation of Unexplained Hematuria

Hematuria, or the presence of blood in the urine, is a critical clinical sign that requires immediate and thorough diagnostic investigation. Whether macroscopic (visible to the naked eye) or microscopic (detected during routine urinalysis), hematuria can indicate underlying pathologies ranging from benign infections to malignant neoplasms. An Ivp with ***NON IONIC*** contrast (DC) allows radiologists to examine the entire mucosal lining of the renal pelvis, ureters, and bladder. It helps detect filling defects, mucosal irregularities, or small transitional cell carcinomas that could be the source of bleeding, providing essential diagnostic data to guide subsequent cystoscopy or biopsy.

Suspected Urolithiasis and Renal Colic

Urolithiasis, the formation of stones within the urinary tract, is a highly prevalent condition that often presents as acute, excruciating flank pain radiating to the groin (renal colic). This pain is frequently accompanied by nausea, vomiting, and dysuria. While non-contrast CT scans are highly sensitive for detecting stones, an IVP provides invaluable functional information. It demonstrates the exact site of ureteral obstruction, the degree of proximal hydronephrosis (kidney swelling), and the functional impact of the stone on renal excretion. This helps urologists determine whether conservative management, shockwave lithotripsy, or surgical intervention is necessary.

Assessment of Congenital Urinary Tract Anomalies

Congenital structural variations of the genitourinary system can remain asymptomatic for years or present early in life with recurrent infections, pain, or palpable masses. These anomalies include duplex collecting systems (duplicated ureters), horseshoe kidney (fusion of the lower poles of the kidneys), renal ectopia (abnormally located kidneys, such as pelvic kidneys), and ureteroceles. The Ivp with ***NON IONIC*** contrast (DC) provides an exceptional anatomical map of these congenital variations, demonstrating the precise course, insertion, and drainage patterns of the ureters, which is crucial for surgical planning and long-term renal preservation.

Investigation of Recurrent Urinary Tract Infections (UTIs)

Chronic or recurrent urinary tract infections, particularly in male patients, children, or young adults, often point to an underlying anatomical or functional abnormality that prevents complete urinary clearance. Urinary stasis acts as a primary breeding ground for bacterial pathogens. By performing an IVP, clinicians can identify structural predisposing factors such as pelviureteric junction (PUJ) obstruction, vesicoureteric junction (VUJ) obstruction, bladder diverticula, or signs of vesicoureteral reflux (VUR) indicated by caliceal blunting. Identifying and correcting these structural issues is key to preventing recurrent infections and chronic pyelonephritis.

Post-Traumatic or Post-Surgical Ureteral Evaluation

The ureters are delicate, narrow tubes that can be vulnerable to injury during major pelvic or abdominal surgeries (such as hysterectomy, colorectal resection, or retroperitoneal lymph node dissection) or as a result of penetrating or blunt abdominal trauma. Ureteral injury can lead to urine leakage (extravasation) into the retroperitoneum or the development of late-stage strictures and complete obstruction. An IVP is an invaluable diagnostic tool to assess ureteral patency, identify the precise site of a suspected leak or stricture, and guide urologists in planning reconstructive or reparative surgical procedures.

What Does a Ivp with ***NON IONIC*** contrast (DC) Detect?

This comprehensive imaging study is highly sensitive in detecting a wide range of structural, functional, and pathological conditions within the urinary tract. The detailed findings include:

• Nephrolithiasis: Calcifications or stones located within the renal parenchyma or collecting system.
• Ureterolithiasis: Calculi lodged within the ureter, causing varying degrees of obstruction.
• Hydronephrosis: Dilation and swelling of the renal pelvis and calyces due to distal obstruction.
• Hydroureter: Abnormal dilation of the ureter proximal to a blockage or stricture.
• Renal Parenchymal Masses: Space-occupying lesions, cysts, or tumors within the kidney tissue that distort the collecting system.
• Transitional Cell Carcinoma (TCC): Malignant tumors of the urothelium, appearing as persistent filling defects in the renal pelvis or ureter.
• Ureteral Strictures: Pathological narrowing of the ureter caused by chronic inflammation, prior surgery, or radiation therapy.
• Pelviureteric Junction (PUJ) Obstruction: Congenital or acquired narrowing at the junction where the renal pelvis meets the ureter.
• Vesicoureteric Junction (VUJ) Obstruction: Obstruction at the point where the ureter enters the urinary bladder.
• Duplex Collecting System: A congenital anomaly characterized by a double pelvis and/or double ureter.
• Horseshoe Kidney: Fusion of the lower poles of both kidneys across the midline of the abdomen.
• Renal Ectopia: Abnormal anatomical positioning of one or both kidneys (e.g., pelvic kidney).
• Ureterocele: A congenital cystic dilation of the terminal portion of the ureter within the bladder.
• Bladder Diverticula: Outpouchings of the bladder wall that can lead to urine stagnation and infection.
• Bladder Calculi: Stones formed or lodged within the urinary bladder.
• Extravasation of Contrast: Leakage of contrast medium outside the urinary tract, indicating a rupture or tear in the ureter or bladder.
• Renal Papillary Necrosis: Sloughing of the renal papillae, presenting as characteristic “ring shadows” or tract formation.
• Chronic Pyelonephritis: Radiographic signs of chronic kidney infection, including parenchymal scarring and caliceal blunting.
• Bladder Outlet Obstruction: Obstruction at the bladder neck, often due to benign prostatic hyperplasia (BPH) or urethral strictures.
• Neurogenic Bladder: Functional bladder abnormalities characterized by altered bladder shape (e.g., “Christmas tree” bladder) and high post-void residual volume.
• Renal Atrophy: Significant reduction in renal size and parenchymal thickness, indicating chronic renal disease.
• Retroperitoneal Fibrosis: Extrinsic compression and medial deviation of the ureters due to retroperitoneal inflammatory tissue.
• Tuberculosis of the Urinary Tract: Chronic inflammatory changes leading to strictures, infundibular stenosis, and a “putty kidney” appearance.
• Vesicoureteral Reflux (VUR) Indicators: Indirect signs of backflow of urine from the bladder into the ureters.
• Post-Void Urinary Retention: Inability to empty the bladder completely, quantified on the post-void radiograph.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic reports are crucial for effective clinical decision-making and reducing patient anxiety. Once the Ivp with ***NON IONIC*** contrast (DC) is completed, the serial radiographic films are compiled and presented to our experienced consultant radiologists. The radiologist meticulously reviews the scout film, the dynamic contrast transit phases, the anatomical structures, and the post-void images. A comprehensive, detailed diagnostic report is then drafted, detailing all normal and pathological findings.

The finalized report and high-quality digital images are typically available within 24 to 48 hours after the procedure. Dr. Essa Lab provides multiple convenient options for report retrieval. Patients can access and download their reports online through the official Dr. Essa Lab web portal or mobile application using their unique patient ID and password. Additionally, physical copies of the report and high-resolution radiographic films can be collected directly from the main diagnostic center or the respective branch in Karachi where the test was performed. Patients are also notified via SMS as soon as their reports are verified and ready for collection.

Ivp with ***NON IONIC*** contrast (DC) Findings Overview

The following table provides a simplified overview of the anatomical structures evaluated during an IVP procedure, comparing normal physiological findings with potential pathological abnormalities.

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Renal Parenchyma (Nephrogram)	Symmetrical, prompt, and uniform enhancement; smooth renal outlines.	Delayed or absent enhancement; irregular contours; focal scarring; parenchymal thinning.
Renal Pelvis & Calyces	Sharp caliceal cupping; normal size and symmetrical filling of the renal pelvis.	Caliceal blunting or clubbing; dilation (hydronephrosis); filling defects (stones, tumors).
Ureters (Course & Caliber)	Smooth, continuous transit of contrast; normal caliber; anatomical midline course.	Persistent dilation (hydroureter); localized strictures; medial/lateral deviation; extravasation.
Urinary Bladder	Smooth mucosal margins; symmetrical filling; normal capacity and contour.	Irregular mucosal margins; filling defects (calculi, masses); diverticula; trabeculation.
Contrast Transit Time	Prompt excretion visible in calyces within 3 to 5 minutes post-injection.	Delayed excretion or complete absence of contrast transit (non-functioning kidney).
Post-Void Residual Volume	Complete or near-complete emptying of the bladder on the post-void film.	Significant residual urine volume; bladder outlet obstruction; neurogenic bladder features.
Ureteral Orifices (VUJ)	Normal, symmetrical entry of contrast into the bladder base.	Ureterocele (“cobra-head” deformity); stricture or obstruction at the vesicoureteric junction.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Ivp with ***NON IONIC*** contrast (DC)?

Selecting the right diagnostic facility is paramount to ensuring safety, accuracy, and a comfortable patient experience. Dr. Essa Lab is widely recognized as a leader in diagnostic services in Karachi, Pakistan, offering several key advantages:

• Experienced Healthcare Professionals: Our team consists of highly qualified consultant radiologists and certified imaging technologists who specialize in advanced uroradiology procedures.
• Patient-Focused Care: We prioritize patient comfort and safety at every step, providing clear explanations and compassionate care to alleviate any anxiety.
• Premium Non-Ionic Contrast Media: We exclusively utilize high-quality, low-osmolality non-ionic contrast agents to minimize the risk of allergic reactions and ensure patient safety.
• Modern Diagnostic Approach: Our facilities are equipped with state-of-the-art digital radiography and fluoroscopy systems that deliver high-resolution images with optimized, low-dose radiation.
• Convenient Online Report Access: Patients can easily view, download, and share their diagnostic reports and digital images online via our secure web portal or mobile app.
• Rigorous Quality Control: Dr. Essa Lab adheres to strict international diagnostic standards and quality control protocols, ensuring highly reliable and accurate reporting.
• Extensive Branch Network: With multiple convenient locations across Karachi, patients can easily access our services, pre-procedure consultations, and report collection facilities.
• Comprehensive Diagnostic Services: We offer a complete range of supporting tests, including serum creatinine, eGFR, and follow-up ultrasounds, all under one roof for seamless patient care.